Comparison · NCT01795859-0fce3400
SD-809 Tablets vs SD-809 Placebo: Number of Participants With Treatment Success at the End of Therapy Based on Clinical Global Impression of Change (CGIC)
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. SD-809 Tablets vs SD-809 Placebo: Number of Participants With Treatment Success at the End of Therapy Based on Clinical Global Impression of Change (CGIC). Trial comparisons, record NCT01795859-0fce3400. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01795859-0fce3400
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.422 | 0.29 | 0.567 | wilson | |
| Risk in group 2 | 0.133 | 0.0626 | 0.262 | wilson | |
| Risk difference, group 1 minus group 2 | 0.289 | 0.104 | 0.45 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 3.17 | 1.4 | 7.19 | log | |
| Odds ratio, group 1 over group 2 | 4.75 | 1.67 | 13.5 | log | |
| Number needed to treat, for one more participant with the outcome on SD-809 Tablets than on SD-809 Placebo | 3.46 | 2.22 | 9.59 | from the risk difference interval |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: placebo.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | SD-809 Tablets | SD-809: SD-809 tablets are available in three dose strengths: 6, 9 and 12 mg, all of which are identical in size, shape and color (white). | 19 | 45 | OG000 |
| Group 2 | SD-809 Placebo | Placebo: Placebo tablets are identical in appearance to SD-809 tablets. | 6 | 45 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Number of Participants With Treatment Success at the End of Therapy Based on Clinical Global Impression of Change (CGIC)
- Description
A treatment success is defined as Much or Very Much Improved at the Week 12 visit. The PGIC is a 7-point Likert Scale, ranging from very much worse to very much improved. The clinician was asked to comment about the subject.
- Time frame
- 12 weeks
- Population
- The Modified ITT (mITT) Population was defined as all subjects in the ITT Population who received study drug and had at least one post-baseline assessment.
Source ClinicalTrials.gov
Trial
- Title
- First Time Use of SD-809 in Huntington Disease
- NCT number
- NCT01795859
- Phases
- PHASE3
- Conditions
- Chorea
- Interventions
- SD-809, Placebo
- Lead sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Results first posted
- 2017-08-11
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT01795859?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT01795859-0fce3400